Effect of ScrF I polymorphism in the 2nd intron of the HMGCR gene on lipid-lowering response to simvastatin in Chinese diabetic patients
Authors:
- 16 November 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 363 (2) , 395-398
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Mechanisms, Significance and Treatment of Vascular Dysfunction in Type 2 Diabetes MellitusDrugs, 2005
- Current practice in the treatment of hyperlipidaemiasExpert Opinion on Pharmacotherapy, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- AtorvastatinExpert Opinion on Pharmacotherapy, 2001
- Pharmacology and clinical experience with simvastatinExpert Opinion on Pharmacotherapy, 2001
- Statins and Blockers of the Renin-Angiotensin SystemHypertension, 1999
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998
- Prospective Study of Small LDLs as a Risk Factor for Non–Insulin Dependent Diabetes Mellitus in Elderly Men and WomenCirculation, 1995
- Regulation of the mevalonate pathwayNature, 1990
- Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIAJournal of Clinical Investigation, 1973